<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Paraoxonase 1 (PON1), an A-esterase with peroxidase-like activity present on the surface of <z:chebi fb="17" ids="39025">HDL</z:chebi>, decreases the peroxidation of <z:chebi fb="15" ids="39026">LDL</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>Serum PON1 activity (PON1a) decreases with aging and in disorders associated with a high risk of adverse cardiovascular events (<z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo>, <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo>, and <z:hpo ids='HP_0003774'>chronic renal failure</z:hpo>) </plain></SENT>
<SENT sid="2" pm="."><plain>The implication of vascular factors in Alzheimer-type <z:hpo ids='HP_0000726'>dementia</z:hpo> (ATD) is strongly suspected </plain></SENT>
<SENT sid="3" pm="."><plain>We measured PON1a by spectrophotometry using the <z:chebi fb="0" ids="27827">paraoxon</z:chebi> substrate in 180 healthy subjects (controls; mean age: 75.3 +/- 8.9 years; 98 women) and 154 patients admitted for cognitive testing </plain></SENT>
<SENT sid="4" pm="."><plain>According to criteria, 45 patients had mild <z:hpo ids='HP_0100543'>cognitive impairments</z:hpo> (MCI; mean age: 75.6 +/- 9.3 years; 28 women), 60 had ATD (mean age: 75.6 +/- 8.3 years; 47 women), and 49 had vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (VaD; mean age: 77.5 +/- 7.2 years; 33 women) </plain></SENT>
<SENT sid="5" pm="."><plain>Mean PON1a was lower in VaD (0.25 +/- 0.1 U/mL) than in controls or ATD (both 0.41 +/- 0.2 U/mL, p &lt; 0.01) </plain></SENT>
<SENT sid="6" pm="."><plain>Mean PON1a values in MCI (0.34 +/- 0.2 U/mL) and ATD (0.41 +/- 0.2 U/mL) were not significantly different </plain></SENT>
<SENT sid="7" pm="."><plain>In multiple linear regression, PON1a was negatively correlated with male sex, age, and VaD, and positively correlated with ATD (each correlation p &lt; 0.001) </plain></SENT>
<SENT sid="8" pm="."><plain>As shown in other high-risk <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disorders</z:e>, PON1a seems to be a reliable marker of VaD </plain></SENT>
<SENT sid="9" pm="."><plain>Its modification in <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> supports the implication of vascular risk factors in this type of <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
</text></document>